Furthermore, in MDA-MB-231 as well as MDA-MB-436 and MCF-7 breast cancer cells, the MTT-based viability was increased by the overexpression of PABPC1 and reduced by the silencing of PABPC1 (Fig. 6E, Supplementary Fig. 6A). This evidence concerns the gene PABPC1 and breast carcinoma.